Publisher: Magna Intelligence
Category: Prescription Drugs

Prescription Drugs market research reports by Magna Intelligence

(17 reports matching your criteria)
    • Global Allergic Rhinitis Databank Market Report

      Global Allergic Rhinitis Databank Market Report The Allergic Rhinitis market was valued at $3,150.0 Million in 2020, and is projected to reach $5,212.2 Million by 2029 growing at a CAGR of 5.80% from 2021 to 2029. Perennial Allergic Rhinitis segment is expected to be the highest contributor to this ... Read More

    • Global Attention Deficit Hyperactivity Disorder Databank Market Report

      Global Attention Deficit Hyperactivity Disorder Databank Market Report The Attention Deficit Hyperactivity Disorder market was valued at $567.0 Million in 2020, and is projected to reach $1,051.5 Million by 2029 growing at a CAGR of 7.15% from 2021 to 2029. Stimulants segment is expected to be the h ... Read More

    • Global Anterior Uveitis Treatment Databank Market Report

      Global Anterior Uveitis Treatment Databank Market Report The Anterior Uveitis Treatment market was valued at $282.4 Million in 2022, and is projected to reach $401.9 Million by 2031 growing at a CAGR of 4.04% from 2023 to 2031. Corticosteroids segment is expected to be the highest contributor to thi ... Read More

    • Global Anti-Tumor Drugs Databank Market Report

      Global Anti-Tumor Drugs Databank Market Report The Anti-Tumor Drugs market was valued at $451,922.8 Million in 2020, and is projected to reach $976,438.3 Million by 2029 growing at a CAGR of 8.98% from 2021 to 2029. Chemotherapy segment is expected to be the highest contributor to this market, with ... Read More

    • Global Medication Management System Databank Market Report

      Global Medication Management System Databank Market Report The Medication Management System market was valued at $2,615.8 Million in 2022, and is projected to reach $5,552.8 Million by 2031 growing at a CAGR of 8.78% from 2023 to 2031. Clinical Decision Support System Solutions segment is expected t ... Read More

    • Global Ophthalmology Drugs Databank Market Report

      Global Ophthalmology Drugs Databank Market Report The Ophthalmology Drugs market was valued at $37,185.8 Million in 2022, and is projected to reach $65,242.2 Million by 2031 growing at a CAGR of 6.49% from 2023 to 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this marke ... Read More

    • Global Antiplatelet Databank Market Report.pdf

      Global Antiplatelet Databank Market Report.pdf The Varicose Veins Treatment Devices market was valued at $1,315.6 Million in 2022, and is projected to reach $2,104.4 Million by 2031 growing at a CAGR of 5.40% from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this ... Read More

    • Global Antiplatelet Databank Market Report

      Global Antiplatelet Databank Market Report The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, ... Read More

    • Global E-Prescribing Databank Market Report

      Global E-Prescribing Databank Market Report The E-Prescribing market was valued at $2,718.6 Million in 2022, and is projected to reach $18,059.0 Million by 2031 growing at a CAGR of 23.56% from 2023 to 2031. Solutions segment is expected to be the highest contributor to this market, with $1,822.5 Mi ... Read More

    • Global Myasthenia Gravis Treatment Databank Market Report

      Global Myasthenia Gravis Treatment Databank Market Report The Myasthenia Gravis Treatment market was valued at $1,362.2 Million in 2022, and is projected to reach $2,372.1 Million by 2031 growing at a CAGR of 6.40% from 2023 to 2031. Medication segment is expected to be the highest contributor to th ... Read More

    • Global Myeloproliferative Disorders Drugs Databank Market Report

      Global Myeloproliferative Disorders Drugs Databank Market Report The Myeloproliferative Disorders Drugs market was valued at $8,315.6 Million in 2022, and is projected to reach $9,998.2 Million by 2031 growing at a CAGR of 2.11% from 2023 to 2031. Ph+ CML segment is expected to be the highest contri ... Read More

    • Global Optogenetics Databank Market Report

      Global Optogenetics Databank Market Report The Optogenetics market was valued at $112.3 Million in 2022, and is projected to reach $172.3 Million by 2031 growing at a CAGR of 4.91% from 2023 to 2031. Actuators segment is expected to be the highest contributor to this market, with $55.6 Million in 20 ... Read More

    • Leading Onychomycosis Treatment Country Markets Databank

      Leading Onychomycosis Treatment Country Markets Databank The Onychomycosis Treatment market was valued at $4,200.0 Million in 2020, and is projected to reach $11,101.3 Million by 2029 growing at a CAGR of 11.47% from 2021 to 2029. North America is expected to be the highest contributor to this marke ... Read More

    • North America Onychomycosis Treatment Market Databank

      North America Onychomycosis Treatment Market Databank The Onychomycosis Treatment market was valued at $4,200.0 Million in 2020, and is projected to reach $11,101.3 Million by 2029 growing at a CAGR of 11.47% from 2021 to 2029. Drug treatment segment is expected to be the highest contributor to this ... Read More

    • Leading Onychomycosis Treatment Drug Class Markets Databank

      Leading Onychomycosis Treatment Drug Class Markets Databank The Onychomycosis Treatment market was valued at $4,200.0 Million in 2020, and is projected to reach $11,101.3 Million by 2029 growing at a CAGR of 11.47% from 2021 to 2029. Allylamine segment is expected to be the highest contributor to th ... Read More

    • Leading Onychomycosis Treatment Treatment Type Markets Databank

      Leading Onychomycosis Treatment Treatment Type Markets Databank The Onychomycosis Treatment market was valued at $4,200.0 Million in 2020, and is projected to reach $11,101.3 Million by 2029 growing at a CAGR of 11.47% from 2021 to 2029. Drug treatment segment is expected to be the highest contribu ... Read More

    • Global Onychomycosis Treatment Market Databank

      Global Onychomycosis Treatment Market Databank The Onychomycosis Treatment market was valued at $4,200.0 Million in 2020, and is projected to reach $11,101.3 Million by 2029 growing at a CAGR of 11.47% from 2021 to 2029. Drug treatment segment is expected to be the highest contributor to this market ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings